Nymox Pharmaceutical Corp (NYMX) - Financial and Strategic SWOT Analysis Review
August 2019
38
About the Report
About the Report
Nymox Pharmaceutical Corp (NYMX)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description-A detailed description of the company's operations and business divisions.
- Corporate strategy-Analyst's summarization of the company's business strategy.
- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.
- Company history-Progression of key events associated with the company.
- Major products and services-A list of major products, services and brands of the company.
- Key competitors-A list of key competitors to the company.
- Key employees-A list of the key executives of the company.
- Executive biographies-A brief summary of the executives' employment history.
- Key operational heads-A list of personnel heading key departments/functions.
- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Nymox Pharmaceutical Corp (Nymox) is a biopharmaceutical company that undertakes the research and development of therapeutics and diagnostics devices to target the unmet needs of the aging population. The company markets diagnostic products for measuring tobacco product exposure and for the diagnosis of Alzheimer's disease. Its diagnostic product portfolio includes NicAlert test to determine smoking status; and TobacAlert home test to determine person's level of exposure to tobacco products, including second hand smoke. Nymox's lead drug candidate, NX-1207 intended for the treatment of BPH (benign prostatic hyperplasia) and certain types of cancer.. The company offers it products across North America, Asia and Europe through its own marketing arm; distributors and medical representatives. Nymox is headquartered in Nassau, the Bahamas.
Nymox Pharmaceutical Corp Key Recent Developments
Mar 19,2019: Nymox Pharmaceutical names Mark Staples PhD as Vice President of Chemistry, Manufacturing and Controls
Mar 13,2019: Nymox announces appointment of Russell Thomson Ph.D. as Director of Quality and EU Qualified Person for company's manufacturing operations
Jul 02,2018: NYMOX Announces Expanded Marketing Plans
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Products
Products
Nymox Pharmaceutical Corp, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts
Companies
Siemens Medical Solutions USA Inc
Roche Diagnostics Corp
Quest Diagnostics Inc
OraSure Technologies Inc
Mossman Associates Inc
Laboratory Corp of America Holdings
GFC Diagnostics Ltd
Eli Lilly and Co
Abraxis LLC
Abbott Canada Inc
Table of Contents
Table of Contents
Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1-About the Company
Nymox Pharmaceutical Corp-Key Facts
Nymox Pharmaceutical Corp-Key Employees
Nymox Pharmaceutical Corp-Key Employee Biographies
Nymox Pharmaceutical Corp-Major Products and Services
Nymox Pharmaceutical Corp-History
Nymox Pharmaceutical Corp-Company Statement
Nymox Pharmaceutical Corp-Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2-Company Analysis
Company Overview
Nymox Pharmaceutical Corp-Business Description
Geographical Segment: Canada
Performance
Geographical Segment: Europe & Other
Performance
Geographical Segment: Geographic regions
Overview
Geographical Segment: United States
Performance
Nymox Pharmaceutical Corp-SWOT Analysis
SWOT Analysis-Overview
Nymox Pharmaceutical Corp-Strengths
Nymox Pharmaceutical Corp-Weaknesses
Nymox Pharmaceutical Corp-Opportunities
Nymox Pharmaceutical Corp-Threats
Nymox Pharmaceutical Corp-Key Competitors
Section 3-Company Financial Ratios
Financial Ratios-Capital Market Ratios
Financial Ratios-Annual Ratios
Performance Chart
Financial Performance
Financial Ratios-Interim Ratios
Financial Ratios-Ratio Charts
Section 4-Company's Lifesciences Financial Deals and Alliances
Nymox Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Nymox Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Nymox Pharmaceutical Corp, Recent Deals Summary
Section 5-Company's Recent Developments
Mar 19, 2019: Nymox Pharmaceutical names Mark Staples PhD as Vice President of Chemistry, Manufacturing and Controls
Mar 13, 2019: Nymox announces appointment of Russell Thomson Ph.D. as Director of Quality and EU Qualified Person for company's manufacturing operations
Jul 02, 2018: NYMOX Announces Expanded Marketing Plans
Section 6-Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Figure
List of Figures
Nymox Pharmaceutical Corp, Performance Chart (2014-2018)
Nymox Pharmaceutical Corp, Ratio Charts
Nymox Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Nymox Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019
List of Table
List of Tables
Nymox Pharmaceutical Corp, Key Facts
Nymox Pharmaceutical Corp, Key Employees
Nymox Pharmaceutical Corp, Key Employee Biographies
Nymox Pharmaceutical Corp, Major Products and Services
Nymox Pharmaceutical Corp, History
Nymox Pharmaceutical Corp, Subsidiaries
Nymox Pharmaceutical Corp, Key Competitors
Nymox Pharmaceutical Corp, Ratios based on current share price
Nymox Pharmaceutical Corp, Annual Ratios
Nymox Pharmaceutical Corp, Annual Ratios (Cont...1)
Nymox Pharmaceutical Corp, Interim Ratios
Nymox Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Nymox Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Nymox Pharmaceutical Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.